Tony Quang, MD, JD
Associate Professor and Interim Service Chief for Radiation Oncology at the VA
Locations of Practice
1660 S Columbian Way
Seattle, WA 98108
Dr. Quang is a board-certified Radiation Oncologist who has been practicing medicine for 15 years. He treats cancer patients, teach medical students and residents, conduct research, and review clinical protocols as Chairman of the VA IRB. He takes care of patients at the VA Puget Sound Health Care System.
As an Attorney, his areas of interest include medical malpractice, contracts, clinical trials protocols, FDA regulation, and intellectual property law.
Patient Care Philosophy
“I became a doctor and specialized in oncology because I like to take care of people at a difficult and transitional time in their lives. My approach is not only to address a patient’s physical health, but also to take care of their mental, emotional, and spiritual health. I believe that advances in technology and medical therapeutics coupled with a sense of compassion and social justice will improve the quality of life of patients afflicted with cancer and will hopefully eradicate this disease.”
Education and Training
College: University of California, Berkeley, Berkeley, CA, 1996
Postgraduate Fellowship: Signal Transduction, University of California, Berkeley, Berkeley, CA, 1997
Medical Education: MCP Hahnemann School of Medicine, Philadelphia, PA, 2002
Internship: Drexel University College of Medicine, Philadelphia, PA, 2003
- Radiation Oncology, Drexel University College of Medicine, Philadelphia, PA, 2004
- Radiation Oncology, University of California Davis Cancer Center, Sacramento, CA, 2007
Legal Education: University of Washington School of Law, Seattle, WA, 2013
Selected Publications from a Total of 16
Prabhu AR, Funahashi R, Gupta R, Adeeb N, Moore JM, Griessenauer C, Agarwal N, Heron DE, Quang TS, Beriwal S. A National Westlaw Database Analysis of Malpractice Litigation in Radiation Oncology. (Fred Pract, 2017, in press)
Gensheimer MF, Hummel-Kramer SM, Cain D, Quang TS. Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy. Medical Dosimetry
Kim J, Li L, Quang TS, Li L, Emrich JG, Kim J, Yaeger TE, Janrette JM, Cohen SC, Black P, Brady LW. Phase II trial of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of anaplastic astrocytoma. J Radiat Oncol 08/2013.
Quang TS. Primary Intracranial Neoplasms. In: Brady LW and Yaeger TE, eds. Encyclopedia of Radiation Oncology. New York, NY: Springer-Verlag Berlin Heidelberg, 2012, 649-657.
Quang TS, Li L. Spinal Canal Tumors. In: Brady LW and Yaeger TE, eds. Encyclopedia of Radiation Oncology. New York, NY: Springer-Verlag Berlin Heidelberg, 2012, 803-809.
Quang TS. A Peer-to-Peer Network: Bridging the Health Care Gap. The JURIST – Dateline, Oct. 17, 2012, http://jurist.org/dateline/2012/10/tony-quang-health-care.php
Patel S, Pakish J, Yen P, Quang T, Carr L, Wood D, Eaton K, Mulligan M, Martins R. Evaluation of Failure Patterns Using Trimodality in Non-Small Cell Lung Cancer. W J Oncol 2011;2(2):64-69.
Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW. A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug;113(2):192-8.
Quang TS, Wallner KE, Herstein PR, Palo BM, Walker JB, Sutlief S. Technologic Evolution in Prostate Cancer Management: Clinical, Financial and Legal Implications for Managed Care Organizations. Oncology November 30, 2007;21(13):1598-1604.
Quang TS, Brady LW. Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):972-5. Review.